Investigator's Choice Chemotherapy
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for Investigator's Choice Chemotherapy, covering 2025-07-03 to 2026-01-22. Get the full timeline:
Most recent: Clinical Trial Update: FDA018-ADC vs Investigator's Choice Chemotherapy to Treat Locally Advanced, Recurrent or Metastatic Triple-negative Breast Cancer [Phase 3]